PubMed Health⌕ Search

PubMed · 16163003

Complexity of the relation between physical activity and stroke: a meta-analysis.

Abstract

OBJECTIVE: To explore the associations of recreational and occupational physical activity with ischemic and hemorrhagic stroke by means of meta-analysis. DATA SOURCES: PUBMED was searched for studies published in English up to December 2001. Keywords used were physical activity, exercise, cerebrovascular disease, stroke, ischaemic stroke, and haemorrhagic stroke. Reference lists were reviewed for additional studies. STUDY SELECTION: Cohort and case-control studies investigating the relation between physical activity and stroke were identified (n = 36). The article reporting the longest follow-up time was included if there was > or =1 report of the same study (4 exclusions). Studies had to report a measure of physical activity. A study that measured physical fitness was excluded. DATA EXTRACTION: Details of study methods, samples, levels of physical activity, types of stroke, and estimates of risk (relative risk, RR) were extracted independently by 3 reviewers from the 24 cohort and 7 case-control studies that were included. Authors of relevant studies were contacted to obtain missing data. Risk estimates were standardized. Risks for subgroups within the samples (e.g., women and men) were treated as separate study units. Physical activity was separated into occupational and leisure activity. MAIN RESULTS: In studies of occupational activity, risk of hemorrhagic stroke (RR, 0.31; 95% CI, 0.13-0.76; 1 study) and risk of ischemic stroke (RR, 0.57; CI, 0.43-0.77; 5 studies) were lower for people most active versus inactive at work, risk of ischemic stroke was lower for people who were most active versus moderately active (RR, 0.77; CI, 0.60-0.98; 5 studies), and risk of total stroke was lower for people moderately active versus inactive (RR, 0.64; CI, 0.48-0.87; 4 studies), but none of the other 8 comparisons of level of occupational activity showed significant differences. In studies of leisure-time activity, risk of total stroke (RR, 0.78; CI, 0.71-0.85; 19 studies), risk of hemorrhagic stroke (RR, 0.74; CI, 0.57-0.96, 9 studies), and risk of ischemic stroke (RR, 0.79; CI, 0.69-0.91; 11 studies) were lower for people most active versus inactive. Risk of total stroke was lower for people moderately active versus inactive (RR, 0.85; CI, 0.78-0.93; 15 studies), but none of the other 7 comparisons showed significant differences. In regression analysis weighted by methodologic quality, RR of stroke for active persons was slightly lower, with narrower confidence intervals. Leisure-time activity compared with inactivity was associated with a greater reduction in risk of hemorrhagic stroke in men (RR, 0.54; CI, 0.36-0.81) than in women (RR, 0.76; CI, 0.67-0.86). Studies conducted in Europe found more effect of activity (RR, 0.47; CI, 0.33-0.66; 3 studies) than US studies (RR, 0.82; CI, 0.75-0.90). Study results did not differ by type of study or year of publication. CONCLUSIONS: Recreational and occupational physical activity were both associated with reductions in risk of stroke. Studies varied widely in their estimates of risk; lower risks were found for active versus inactive men than women and for European versus US studies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wieslaw Oczkowski. 2005. Complexity of the relation between physical activity and stroke: a meta-analysis.. https://doi.org/10.1097/01.jsm.0000179228.78532.45

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗